Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden

Virulence. 2021 Dec;12(1):1296-1305. doi: 10.1080/21505594.2021.1922010.

Abstract

Shiga toxin-producing Escherichia coli, a foodborne bacterial pathogen, has been linked to a broad spectrum of clinical outcomes ranging from asymptomatic carriage to fatal hemolytic uremic syndrome (HUS). Here, we collected clinical data and STEC strains from HUS patients from 1994 through 2018, whole-genome sequencing was performed to molecularly characterize HUS-associated STEC strains, statistical analysis was conducted to identify bacterial genetic factors associated with severe outcomes in HUS patients. O157:H7 was the most predominant serotype (57%) among 54 HUS-associated STEC strains, followed by O121:H19 (19%) and O26:H11 (7%). Notably, some non-predominant serotypes such as O59:H17 (2%) and O109:H21 (2%) also caused HUS. All O157:H7 strains with one exception belonged to clade 8. During follow-up at a median of 4 years, 41% of the patients had renal sequelae. Fifty-nine virulence genes were found to be statistically associated with severe renal sequelae, these genes encoded type II and type III secretion system effectors, chaperones, and other factors. Notably, virulence genes associated with severe clinical outcomes were significantly more prevalent in O157:H7 strains. In contrast, genes related to mild symptoms were evenly distributed across all serotypes. The whole-genome phylogeny indicated high genomic diversity among HUS-STEC strains. No distinct cluster was found between HUS and non-HUS STEC strains. The current study showed that O157:H7 remains the main cause of STEC-associated HUS, despite the rising importance of other non-O157 serotypes. Besides, O157:H7 is associated with severe renal sequelae in the follow-up, which could be a risk factor for long-term prognosis in HUS patients.

Keywords: O157:H7; Shiga toxin-producing Escherichia coli; clinical outcomes; hemolytic uremic syndrome; virulence genes; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli Infections* / epidemiology
  • Genomics
  • Hemolytic-Uremic Syndrome* / epidemiology
  • Humans
  • Serogroup
  • Shiga-Toxigenic Escherichia coli* / genetics
  • Sweden / epidemiology

Grants and funding

This work was supported by the Scandinavian Society for Antimicrobial Chemotherapy Foundation under grant[SLS884041]; National Natural Science Foundation of China under grant [81701977];and the Natural Science Foundations of Guangdong Province under grant [2019A1515111004 and 2021A1515011240]. All funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.